In Other News

• Biomerica Receives CE Mark for New High-Volume Production Version of COVID-19 IgG/IgM Rapid Test

• Hardy Diagnostics’ COVID-19 Antibody Test Granted FDA Emergency Use Authorization

• Eurofins Launches CE-IVD Marked Multiplex Real-Time PCR Assay for SARS-CoV-2 Detection

• Siemens' Fast Track Diagnostics SARS-CoV-2 Test Granted FDA Emergency Use Authorization

• FDA’s Revised Policy Tightens Requirements for COVID-19 Antibody Tests

• PerkinElmer Secures FDA Emergency Use Authorization for EUROIMMUN’s Anti-SARS-CoV-2 ELISA Serology Test

• Antibody Detection Is Critical for COVID-19 Diagnosis

• PlexBio Receives CE Mark for PCR-based Coronavirus Detection Kit

• BioMérieux's BioFire SARS-CoV-2 Respiratory Panel Obtains FDA Emergency Use Authorization

• Bio-Rad ddPCR COVID-19 Assay Secures FDA Emergency Use Authorization

• Roche’s COVID-19 Antibody Test Receives FDA Emergency Use Authorization

• Quotient Limited Receives CE Mark for Its SARS-CoV-2 (COVID-19) Antibody Microarray

• Hologic Launches Second High-Throughput Molecular Assay for Novel Coronavirus

• Avacta and Adeptrix Collaborate to Develop Coronavirus Antigen Test Using Mass Spectrometry

• Bio-Rad’s SARS-CoV-2 Serology Test Becomes First Total COVID Antibody Test to Secure FDA EUA

• Aalto Bio Launches Lysis Buffer Reagent for COVID-19 Testing

• Altona Diagnostics Receives Emergency Use Authorization from US FDA for RealStar SARS-CoV-2 RT-PCR Kit US

• NIH’s RADx Initiative to Speed Development of Rapid and Widely Accessible COVID-19 Testing

• BillionToOne COVID-19 Test with 30X Higher Throughput Could Unlock Millions of Daily Testing Capacity Worldwide

• Study of COVID-19 POC Tests Finds Antibody Tests Can Complement PCR Diagnostics

• Rheonix Receives FDA Emergency Use Authorization for Rapid, Fully Automated Molecular COVID-19 Test

• SEASUN BIOMATERIALS Launches COVID-19 Rapid Molecular Assay

• Harvard-Designed Injection-Molded Nasopharyngeal Swabs For COVID-19 Enter Human Trials